- Home
- NCRA vs NERV Comparison
NCRA vs NERV Comparison
Compare NCRA & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCRA
- NERV
- Stock Information
- Founded
- NCRA 2002
- NERV 2007
- Country
- NCRA Taiwan
- NERV United States
- Employees
- NCRA N/A
- NERV N/A
- Industry
- NCRA Farming/Seeds/Milling
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- NCRA Consumer Staples
- NERV Health Care
- Exchange
- NCRA Nasdaq
- NERV Nasdaq
- Market Cap
- NCRA 15.4M
- NERV 12.6M
- IPO Year
- NCRA N/A
- NERV 2014
- Fundamental
- Price
- NCRA $1.02
- NERV $1.77
- Analyst Decision
- NCRA
- NERV Hold
- Analyst Count
- NCRA 0
- NERV 1
- Target Price
- NCRA N/A
- NERV $5.00
- AVG Volume (30 Days)
- NCRA 54.7K
- NERV 12.2K
- Earning Date
- NCRA 08-13-2025
- NERV 08-05-2025
- Dividend Yield
- NCRA N/A
- NERV N/A
- EPS Growth
- NCRA N/A
- NERV N/A
- EPS
- NCRA N/A
- NERV 0.83
- Revenue
- NCRA $16,647,379.00
- NERV N/A
- Revenue This Year
- NCRA N/A
- NERV N/A
- Revenue Next Year
- NCRA N/A
- NERV N/A
- P/E Ratio
- NCRA N/A
- NERV $2.18
- Revenue Growth
- NCRA N/A
- NERV N/A
- 52 Week Low
- NCRA $0.70
- NERV $1.15
- 52 Week High
- NCRA $2.09
- NERV $3.50
- Technical
- Relative Strength Index (RSI)
- NCRA 50.60
- NERV 57.10
- Support Level
- NCRA $0.87
- NERV $1.62
- Resistance Level
- NCRA $1.05
- NERV $1.83
- Average True Range (ATR)
- NCRA 0.07
- NERV 0.09
- MACD
- NCRA -0.00
- NERV -0.00
- Stochastic Oscillator
- NCRA 65.79
- NERV 64.29
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.